Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 216 entries
View as:

A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT06568237 Org: User:
Start: 10/02/24 End: 06/17/27 Due: 06/17/28

Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time

Phase: N/A Priority: Normal
NCT ID: NCT01240863 Org: User:
Start: 11/30/10 End: 08/31/11 Due: 08/31/12

Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT02629861 Org: User:
Start: 03/23/16 End: 04/10/17 Due: 04/10/18

Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Participants With Moderate to Severe Pain Following Bunionectomy

Phase: N/A Priority: Normal
NCT ID: NCT02487108 Org: User:
Start: 08/11/15 End: 03/30/16 Due: 03/30/17

Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00988247 Org: User:
Start: 10/31/09 End: 02/28/11 Due: 02/28/12

An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)

Phase: N/A Priority: Normal
NCT ID: NCT01578785 Org: User:
Start: 03/31/12 End: 11/30/12 Due: 11/30/13

A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)

Phase: N/A Priority: Normal
NCT ID: NCT03571256 Org: User:
Start: 05/31/18 End: 12/09/19 Due: 12/09/20

A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age

Phase: N/A Priority: Normal
NCT ID: NCT04682353 Org: User:
Start: 12/14/20 End: 01/12/23 Due: 01/12/24

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02040766 Org: User:
Start: 12/31/13 End: 03/31/16 Due: 03/31/17

Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

Phase: N/A Priority: Normal
NCT ID: NCT01126190 Org: User:
Start: 06/30/10 End: 02/29/12 Due: 02/28/13

A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod

Phase: N/A Priority: Normal
NCT ID: NCT02215616 Org: User:
Start: 10/28/14 End: 06/19/18 Due: 06/19/19

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

Phase: N/A Priority: Normal
NCT ID: NCT00877006 Org: User:
Start: 04/30/09 End: 03/31/12 Due: 03/31/13

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Phase: N/A Priority: Normal
NCT ID: NCT00977665 Org: User:
Start: 12/31/09 End: 10/31/11 Due: 10/31/12

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01772368 Org: User:
Start: 01/31/13 End: 06/30/13 Due: 06/30/14

A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00665223 Org: User:
Start: 04/24/08 End: 06/14/10 Due: 06/14/11

Fremanezumab Compassionate Use Program for Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT03539393 Org: User:
Start: - End: - Due: -

Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01723228 Org: User:
Start: 11/30/12 End: 01/31/15 Due: 01/31/16

The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Phase: N/A Priority: Normal
NCT ID: NCT01707992 Org: User:
Start: 02/20/13 End: 07/04/17 Due: 07/04/18

A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Phase: N/A Priority: Normal
NCT ID: NCT01975298 Org: User:
Start: 01/31/14 End: 03/31/14 Due: 03/31/15

First Time Use of SD-809 in Huntington Disease

Phase: N/A Priority: Normal
NCT ID: NCT01795859 Org: User:
Start: 08/05/13 End: 12/05/14 Due: 12/05/15

Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01290887 Org: User:
Start: 06/30/11 End: 01/31/15 Due: 01/31/16

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00203177 Org: User:
Start: 10/31/01 End: - Due: -

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06664619 Org: User:
Start: 12/12/24 End: 05/31/26 Due: 05/31/27

Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01088984 Org: User:
Start: 08/31/10 End: 08/31/11 Due: 08/31/12

A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel

Phase: N/A Priority: Normal
NCT ID: NCT00868361 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10